文献速递创伤与烧伤复苏、休克与脓毒症

组蛋白去乙酰化酶6抑制剂ACY-1083改善致命性出血、多发伤和菌血症猪模型的生存率

Histone deacetylase 6 inhibition improves survival in a swine model of lethal hemorrhage, polytrauma, and bacteremia.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论在致命性出血、多发伤和菌血症猪模型中,单剂ACY-1083 30 mg/kg使生存率从0%提高至80%(p=0.019)。

本研究在猪模型中模拟45%血容量出血、脑损伤、股骨骨折、腹直肌挤压伤、脾肝裂伤及结肠损伤,休克1小时后随机给予生理盐水复苏(对照组)或生理盐水加ACY-1083 30 mg/kg治疗(每组5只)。3小时后(模拟延迟后送)输注浓缩红细胞和抗生素、修复结肠损伤并关腹,再监测4小时。对照组生存率为0%,ACY-1083组提高至80%(p=0.019),两组脑 lesion 大小无差异。结论认为单剂ACY-1083在原本致命的多发伤、出血性休克和菌血症模型中显著改善生存。

要点

  • 在猪多发伤、出血性休克和菌血症模型中,对照组生存率0%,ACY-1083 30 mg/kg组生存率80%(p=0.019)。
  • 所有动物均出现菌血症,合并严重出血性休克;该损伤组合本身致命。
  • ACY-1083为组蛋白去乙酰化酶6异构体特异性抑制剂,单剂给药。
  • 两组脑 lesion 大小无差异。

适用人群与场景

  • 猪模型:经历45%血容量出血、脑损伤、股骨骨折、腹直肌挤压伤、脾和肝裂伤及结肠损伤,休克1小时(平均动脉压30-35 mm Hg)后进入复苏。

处置流程与药物剂量

  • 休克1小时后随机给予生理盐水复苏(对照组)或生理盐水加ACY-1083 30 mg/kg治疗(每组5只)。
  • 3小时后(模拟延迟后送)输注浓缩红细胞和抗生素,修复结肠损伤并关腹,再监测4小时。

研究设计与关键结果

  • 研究类型为猪模型实验;每组5只;干预为ACY-1083 30 mg/kg单剂,对照为生理盐水;主要终点生存率:对照组0% vs ACY-1083组80%(p=0.019)。
  • 两组脑 lesion 大小无差异。
  • 所有动物均出现菌血症,合并严重出血性休克。

证据类型、等级与局限

  • 证据类型:动物实验(猪模型);局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为单剂ACY-1083在原本致命的多发伤、出血性休克和菌血症模型中显著改善生存。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Trauma is the leading cause of death for young Americans. Nonspecific histone deacetylase inhibitors, such as valproic acid, have been shown to improve survival in preclinical models of lethal trauma, hemorrhage, and sepsis. The doses needed to achieve a survival benefit are higher than Food and Drug Administration-approved doses, and the nonspecificity raises concerns about unintended adverse effects. The isoform-specific histone deacetylase 6 inhibitor, ACY-1083, has been found to be as efficacious as valproic acid in a rodent model of hemorrhagic shock. We hypothesized that ACY-1083 treatment would improve survival in a swine model of lethal hemorrhage, polytrauma, and bacteremia.

METHODS: Swine were subjected to 45% blood volume hemorrhage, brain injury, femur fracture, rectus crush, splenic and liver lacerations, and colon injury. After 1 hour of shock (mean arterial pressure, 30-35 mm Hg), animals were randomized to normal saline resuscitation (control) or normal saline plus ACY-1083 30 mg/kg treatment (n = 5/group). After 3 hours (simulating delayed evacuation), packed red blood cells and antibiotics were administered, the colon injury was repaired, and the abdomen was closed. Animals were then monitored for another 4 hours. Survival was assessed using Kaplan-Meier and log-rank test.

RESULTS: This combination of injuries was lethal. All animals became bacteremic, in addition to the severe hemorrhagic shock. Survival in the control group was 0%, and ACY-1083 treatment increased survival to 80% (p = 0.019). There was no difference in the brain lesion size between the groups.

CONCLUSION: A single dose of ACY-1083 markedly improves survival in an otherwise lethal model of polytrauma, hemorrhagic shock, and bacteremia.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Biesterveld BE, Wakam GK, Kemp MT, et al. Histone deacetylase 6 inhibition improves survival in a swine model of lethal hemorrhage, polytrauma, and bacteremia. J Trauma Acute Care Surg. 2020. PMID: 32195993. doi:10.1097/TA.0000000000002677

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。